MacDougall Biomedical Communications, Inc. Company Profile

08:22 EDT 21st June 2018 | BioPortfolio

MacDougall Biomedical Communications Inc.(MBI) was founded in 2002 to fulfill the communications needs of small to medium sized private and public biotechnology companies. The staff at MBI has tremendous industry experience, having provided investor, corporate and scientific outreach programs to over 100 clients in the life sciences industry. MBI works with companies ranging from early stage start-ups that have no internal communications capabilities to billion dollar market cap public companies that have full-time communications staff. MBI has managed major event and visibility projects for the Biotechnology Industry Organization and other regional biotechnology organizations. The team at MBI prides itself in being innovative and creative with a results-oriented approach. MBI has also built a broad network of the best corporate communications specialists worldwide to implement larger programs as needed.
"The most important measurements of success in the biotechnology industry are management's ability to build third-party endorsement of its programs and to proactively manage the expectations of its constituencies…investors, partners, clinical and scientific community, patients, shareholders, media, employees, etc."
- Douglas MacDougall, President, MBI


190 North Main Street3rd Floor
United States of America


Phone: (508) 647-0209
Fax: (508) 647-1501

News Articles [427 Associated News Articles listed on BioPortfolio]

ArunA biomedical study published in Stroke, exosomes improved recovery in stroked pigs

(MacDougall Biomedical Communications, Inc.) ArunA Biomedical announces publication of study in Stroke that reports exosomes improved tissue and functional recovery in pig model of ischemic stroke.

Aquinnah Pharmaceuticals receives $3.4 million grant from NINDS to advance new therapies for ALS

(MacDougall Biomedical Communications, Inc.) Aquinnah Pharmaceuticals, leaders in stress granule biology, an exciting new target for the development of neurodegenerative therapeutics, announced today ...

Axial reports findings of elevated 4-EPS in children with ASD

(MacDougall Biomedical Communications, Inc.) Axial Biotherapeutics today announced that Srinivas Rao, M.D., Ph.D., Axial's Chief Medical Officer, will present new data from Axial's research of the lin...

Positive Phase 2 results of NovaDigm TX's NDV-3A vaccine published in Clinical Infectious Diseases

(MacDougall Biomedical Communications, Inc.) NovaDigm Therapeutics, a company developing innovative immuno-therapeutics and preventative vaccines for fungal and bacterial infections, today announced t...

CENTOGENE to Open First U.S. Laboratory in Cambridge, MA Focused on Rare Genetic Diseases ...

Centogene:Ruxandra Lenz, +49 30 213 000 323Director CommunicationsRuxandra.Lenz@centogene.comorMedia Contact:MacDougall Biomedical CommunicationsLauren Arnold, +1 781-235-3060larn...

Opinion: The NIH is in danger of losing its edge in creating biomedical innovations

Biomedical research in the U.S is flagging. Here's how we would fix it.

#jobs #lifescience Communications Manager

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Communications Manager .MA-Chelmsford, Are you a Communications Manager with ...

New Bionow Service Company of the Year Award to recognise excellence in specialist biomedical service provision and submission deadline extension

Applications are invited from specialist biomedical service companies who meet the criteria detailed in the award application form available at

Drugs and Medications [4 Associated Drugs and Medications listed on BioPortfolio]

Zorbtive [EMD Serono, Inc.]

Zorbtive [somatropin (rDNA origin) for injection]

Fludeoxyglucose [Biomedical Research Foundation of Northwest Louisiana]

These highlights do not include all the information needed to use Fludeoxyglucose F18 Injection safely and effectively. See full prescribing information for Fludeoxyglucose F18 Injection. Fludeoxygluc...

Fludeoxyglucose f18 [Biomedical Research Foundation of Northwest Louisiana]

These highlights do not include all the information needed to use Fludeoxyglucose F18 Injection safely and effectively. See full prescribing information for Fludeoxyglucose F18 Injection. Fludeoxygluc...

Serostim [EMD Serono, Inc.]

Serostim [somatropin (rDNA origin) for injection]

PubMed Articles [352 Associated PubMed Articles listed on BioPortfolio]

Communications of the median nerve in fetuses.

Communications between the median, ulnar and musculocutaneous nerves in the arm, forearm and hand were reported in adult cadaveric and electrophysiological studies. These communicant branches may lead...

Editorial: JCP Communications-Updating a valued community resource.

Simplified Submission Requirements for Authors of JACS Communications.

Adipose Dendritic Cells Come Out of Hiding.

In this issue of Cell Metabolism, Macdougall et al. (2018) identify two subsets of conventional dendritic cells in visceral adipose tissue and demonstrate that these subsets engage distinct adipocyte...

DataMed - an open source discovery index for finding biomedical datasets.

Finding relevant datasets is important for promoting data reuse in the biomedical domain, but it is challenging given the volume and complexity of biomedical data. Here we describe the development of ...

Clinical Trials [116 Associated Clinical Trials listed on BioPortfolio]

How Participants Perceive Biomedical Research in Pulmonology

The primary objective of this study is to determine how biomedical research is perceived by patients already participating in a pulmonology research project.

Bigfoot Biomedical Clinical Research Center (CRC) Trial

The trial is designed to assess safety and feasibility of the Bigfoot Biomedical Type 1 Diabetes Management System (T1DMS) in up to 50 participants in a closely monitored Clinical Research...

Multi-level Communications and Access Strategies to Improve the Food Environment

The overarching goal of B'More Healthy Retail Rewards (BHRR) is to develop, implement, and evaluate a pilot multi-level communications and pricing intervention to improve access to and con...

Setting up a Warehouse of Physiological Data and Biomedical Signals in Adult Intensive Care

The aim of this study is the establishment of a warehouse physiological data and biomedical signal in intensive care adult patients in acute situations from particular records from the Phi...

Effectiveness of Community-Level Behavioral and Biomedical Interventions for Reducing HIV/STIs in Men in Peru

This study will evaluate the effectiveness of community-level behavioral and biomedical interventions, each alone and combined, in reducing sexual risk behavior and HIV/sexually transmitte...

Companies [1019 Associated Companies listed on BioPortfolio]

MacDougall Biomedical Communications, Inc.

MacDougall Biomedical Communications Inc.(MBI) was founded in 2002 to fulfill the communications needs of small to medium sized private and public biotechnology companies. The staff at MBI has tremen...

Russel Welsh

Strategic Communications for the biomedical, life science and pharmaceutical industries.

XO Communications

XO Communications provides the technology that helps business and wholesale customers compete in a hyper-connected economy. In the U.S., XO owns and operates one of the largest IP...


GulfTel Communications is a proud member of the RLEC Division of Madison River Communications.We are a locally-managed company, close to our customers and driven by their needs and expectations. Yet w...

Legend Communications

Legend Communications is one of the leading Converged Communications Providers in the UK offering combined Internet and Telecommunication solutions to residential, business, corporate and partner audi...

More Information about "MacDougall Biomedical Communications, Inc." on BioPortfolio

We have published hundreds of MacDougall Biomedical Communications, Inc. news stories on BioPortfolio along with dozens of MacDougall Biomedical Communications, Inc. Clinical Trials and PubMed Articles about MacDougall Biomedical Communications, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of MacDougall Biomedical Communications, Inc. Companies in our database. You can also find out about relevant MacDougall Biomedical Communications, Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Prostate Cancer
Prostate cancer (cancer de prostata) Prostate cancer (cancer de prostata) is a form of cancer that develops in the prostate, a gland in the male reproductive system. Most prostate cancers are slow growing; however, there are cases of aggressive prostat...

Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Corporate Database Quicklinks

Searches Linking to this Company Record